clinical dementia rating - sum of boxes (CDR-SB)

From Aaushi
Jump to navigation Jump to search

Introduction

Derived from Clinical Dementia Rating score

Procedure

* each domain is scored from 0 (normal) to 3 (severe impairment) the scores are summed to produce the CDR-SB score

Interpretation

More general terms

Additional terms

References

  1. Yang YW, Hsu KC, Wei CY, Tzeng RC, Chiu PY. Operational Determination of Subjective Cognitive Decline, Mild Cognitive Impairment, and Dementia Using Sum of Boxes of the Clinical Dementia Rating Scale. Front Aging Neurosci. 2021 Sep 7;13:705782. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34557083 PMCID: PMC8455062 Free PMC article.
  2. George J Alzheimer's Drug Slows Decline, Trial Data Show. Lecanemab met primary and secondary endpoints, but was associated with adverse events. MedPage Today November 30, 2022 https://www.medpagetoday.com/neurology/alzheimersdisease/101972
    van Dyck CH, Swanson CJ, Aisen P Lecanemab in Early Alzheimer's Disease. N Engl J Med 2022. Nov 29. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36449413 https://www.nejm.org/doi/full/10.1056/NEJMoa2212948